Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | KLK7 | P49862 | 2/20 | 0.52 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.52 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.52 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.52 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.49 |
| ▸ | TGM2 | P21980 | 2/20 | 0.49 |
| ▸ | ITGAV | P06756 | 2/20 | 0.49 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | SYK | P43405 | 1/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | CPB1 | P15086 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2031362 | 0.91 | FOLH1 (0.58) | FOLH1SIRT2SIRT1ITGB3TGM2 | |
| SCHEMBL2367207 | 0.91 | KLK7 (0.51) | MAPTKLK7KLK5PPARASIRT2 | |
| SCHEMBL4850576 | 0.90 | KLK7 (0.50) | MAPTKLK7KLK5SIRT2SIRT1 | |
| SCHEMBL2369249 | 0.90 | MAPT (0.64) | MAPTKLK7KLK5PPARAFOLH1 | |
| SCHEMBL1374913 | 0.90 | MAPT (0.64) | MAPTKLK7KLK5PPARAFOLH1 | |
| SCHEMBL1374918 | 0.90 | MAPT (0.64) | MAPTKLK7KLK5PPARAFOLH1 | |
| SCHEMBL1021938 | 0.87 | SYK (0.60) | MAPTKLK7KLK5PPARAFOLH1 | |
| SCHEMBL4958981 | 0.87 | SYK (0.60) | MAPTKLK7KLK5PPARAFOLH1 | |
| SCHEMBL918813 | 0.87 | SYK (0.60) | MAPTKLK7KLK5PPARAFOLH1 | |
| SCHEMBL2334326 | 0.86 | MAPT (0.68) | MAPTKLK7KLK5PPARAFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071353-A1 | SUBSTRATES, PEPTIDE ARRAYS, AND METHODS | VIBRANT HOLDINGS LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12454771-B2 | Substrates, peptide arrays, and methods | VIBRANT HOLDINGS LLC (US) | 2025-10-28 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| US-20230294063-A1 | SUBSTRATES, PEPTIDE ARRAYS, AND METHODS | VIBRANT HOLDINGS, LLC | 2023-09-21 | — | — | US | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-11565231-B2 | Substrates, peptide arrays, and methods | VIBRANT HOLDINGS, LLC (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230294063-A1 | SUBSTRATES, PEPTIDE ARRAYS, AND METHODS | VIP, IAPP, GIPR | MAPT 3943/4885KLK7 895/4885KLK5 685/4885 |
| US-20260071353-A1 | SUBSTRATES, PEPTIDE ARRAYS, AND METHODS | VIP, CALCB, SPPL2B | MAPT 1028/4885KLK7 678/4885KLK5 1413/4885 |
| US-11565231-B2 | Substrates, peptide arrays, and methods | VIP, IAPP, GIPR | MAPT 3943/4885KLK7 895/4885KLK5 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.